101 related articles for article (PubMed ID: 2139910)
21. Short- and long-term effects of ramipril in hypertension.
de Leeuw PW; Birkenhäger WH
Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038
[TBL] [Abstract][Full Text] [Related]
22. Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
Safar ME; Laurent SL; Bouthier JD; London GM; Mimran AR
J Hypertens Suppl; 1986 Dec; 4(5):S285-9. PubMed ID: 3033179
[TBL] [Abstract][Full Text] [Related]
23. Clinical pharmacology of ramipril.
Ball SG; Robertson JI
Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
[TBL] [Abstract][Full Text] [Related]
24. Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension.
Felder K; Witte PU
Arzneimittelforschung; 1984; 34(10B):1452-4. PubMed ID: 6097273
[TBL] [Abstract][Full Text] [Related]
25. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
Todd PA; Benfield P
Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
[TBL] [Abstract][Full Text] [Related]
26. [Effect of the angiotensin-converting enzyme inhibitor ramipril on proteinuria, blood pressure and kidney function in histologically confirmed glomerulonephritis with nephrotic syndrome].
Götz R; Drechsler U; Heidbreder E; Heidland A
Z Kardiol; 1988; 77 Suppl 3():65-8. PubMed ID: 2975097
[No Abstract] [Full Text] [Related]
27. Effect of ramipril on 24-hour variability of blood pressure and heart rate in essential hypertension.
Tochikubo O; Asahina S; Kaneko Y
Am J Cardiol; 1987 Apr; 59(10):83D-85D. PubMed ID: 3034039
[TBL] [Abstract][Full Text] [Related]
28. [Interaction of chronic inhibition of the angiotensin-converting enzyme and the sympathetic system: effect of added sodium chloride load].
Dominiak P; Blöchl A
Z Kardiol; 1988; 77 Suppl 3():29-33. PubMed ID: 2905555
[No Abstract] [Full Text] [Related]
29. [Long-term blood pressure measurement for evaluating the first dose response of captopril and ramipril in patients with a stimulated renin system].
Lüders S; Schrader J; Schoel G; Ruschitzka F; Scheler F
Z Kardiol; 1992; 81 Suppl 2():41-4. PubMed ID: 1387500
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
Mroczek WJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
Bender N; Rangoonwala B; Rosenthal J; Vasmant D
Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
Guyot D; Lemarié JC
Rev Prat; 1990 Jun; 40(18 Suppl):27-30, 35-8. PubMed ID: 2143596
[TBL] [Abstract][Full Text] [Related]
33. Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study.
Vasmant D; Lendresse P; Lemarie JC; Gallet M
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S144-6. PubMed ID: 1725027
[TBL] [Abstract][Full Text] [Related]
34. [The French ambulatory multicenter trial of Triatec: conclusions of the trial].
Le Menn G
Rev Prat; 1990 Jun; 40(18 Suppl):48-50. PubMed ID: 2143599
[TBL] [Abstract][Full Text] [Related]
35. [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease].
Unterberg C; Buchwald A; Vogt A; Wiegand V
Med Klin (Munich); 1990 Feb; 85(2):78-81. PubMed ID: 2138704
[TBL] [Abstract][Full Text] [Related]
36. The effect of aspirin on serum immunoglobulins.
Waters E; Browne S; Settipane GA
N Engl Reg Allergy Proc; 1986; 7(2):113-6. PubMed ID: 3475541
[TBL] [Abstract][Full Text] [Related]
37. [Changes in protein fractions and serum immunoglobulins in persons occupationally exposed to lead].
Sroczyński J; Bońkowska M; Twardowska-Saucha K; Urbańska-Bonenberg L
Przegl Lek; 1988; 45(7):570-3. PubMed ID: 3238035
[No Abstract] [Full Text] [Related]
38. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
Schnaper HW
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
[TBL] [Abstract][Full Text] [Related]
39. Effects of chronic treatment with ramipril, a new ACE blocking agent, on presynaptic sympathetic nervous system of SHR.
Dominiak P; Elfrath A; Türck D
Clin Exp Hypertens A; 1987; 9(2-3):369-73. PubMed ID: 3038397
[TBL] [Abstract][Full Text] [Related]
40. ACE inhibitors after myocardial infarction.
Hall AS; Ball SG
Lancet; 1989 Dec 23-30; 2(8678-8679):1527. PubMed ID: 2574802
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
